TAK
Takeda Pharmaceutical Company Limited
$14.25
Earnings Summary
Revenue | $1207990Mn |
Net Profits | $95248Mn |
Net Profit Margins | 7.88% |
Highlights
Takeda Pharmaceutical Company Limited’s revenue jumped 15.81% since last year same period to $1207990Mn in the Q2 2024. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 0% jump in its revenue since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit jumped 298.31% since last year same period to $95248Mn in the Q2 2024. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 0% jump in its net profits since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit margin jumped 271.24% since last year same period to 7.88% in the Q2 2024. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 0% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Takeda Pharmaceutical Company Limited post its latest quarter earnings
EPS Estimate Current Quarter | 0.59 |
EPS Estimate Current Year | 0.59 |
Highlights
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.59 - a -21.33% fall from last quarter’s estimates.
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.59.
Key Ratios
Key ratios of the Takeda Pharmaceutical Company Limited post its Q2 2024 earnings
Earning Per Share (EPS) | 0.19 |
Highlights
Takeda Pharmaceutical Company Limited’s earning per share (EPS) fell -6.15% since last year same period to 0.19 in the Q2 2024. This indicates that the Takeda Pharmaceutical Company Limited has generated -6.15% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-29 | -0.01 | -0.01 | 54.23% |
2024-06-30 | 0.75 | 0.19 | -74.36% |
₹0 US Stocks a/c Opening Fee